Related Experiment Video
Updated: Apr 12, 2026
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues
Surbhi Jain1, Ting-Tsung Chang2, Sitong Chen1
1JBS Science, Inc., Doylestown, Pennsylvania.
Insights
Hepatitis B virus (HBV) DNA methylation in CpG island 3 is linked to liver cancer development. This study also found rare non-CpG methylation in HBV, offering new insights into viral pathogenesis.
Area of Science:
- Hepatology
- Virology
- Epigenetics
Background:
- Hepatitis B virus (HBV) causes liver disease, including cirrhosis and hepatocellular carcinoma (HCC).
- The role of HBV DNA methylation in liver disease progression, particularly HCC, remains unclear.
- Understanding HBV DNA methylation patterns may reveal insights into disease pathogenesis.
Purpose of the Study:
- To comprehensively profile DNA methylation across three putative CpG islands within the HBV genome.
- To investigate the correlation between HBV DNA methylation status and liver disease progression, including HCC.
- To explore potential non-CpG methylation within the HBV genome.
Main Methods:
- Bisulfite PCR sequencing was initially used on a small sample set.
- Quantitative bisulfite-specific PCR and methylation-specific PCR assays were employed on a larger cohort (n=116).
- HBV methylation was compared to methylation of host genes (APC, GSTP1, RASSF1A) associated with HCC.
Main Results:
- Methylation levels in HBV CpG island 3 significantly correlated with hepatocarcinogenesis (liver cancer development).
- Evidence of rare, non-CpG methylation was identified in CpG island 2 of the HBV genome.
- No significant correlation was found between HBV genome methylation and the methylation of the studied host HCC-associated genes.
Conclusions:
- HBV CpG island 3 methylation is a potential biomarker for hepatocarcinogenesis.
- The discovery of non-CpG methylation in HBV adds a new dimension to understanding viral epigenetics.
- HBV methylation patterns may act independently of host gene methylation in HCC development.
Abstract:
Hepatitis B virus (HBV) is a hepatotropic virus causing hepatitis, cirrhosis and hepatocellular carcinoma (HCC). The methylation status of the HBV DNA in its different forms can potentially provide insight into the pathogenesis of HBV-related liver diseases, including HCC, however this is unclear. The goal of this study is to obtain comprehensive DNA methylation profiles of the three putative CpG islands in the HBV DNA in infected livers, with respect to liver disease progression. The extent of methylation in these CpG islands was first assessed using bisulfite PCR sequencing with a small set of tissue samples, followed by analysis using both quantitative bisulfite-specific PCR and quantitative methylation-specific PCR assays in a larger sample size (n = 116). The level of HBV CpG island 3 methylation significantly correlated with hepatocarcinogenesis. We also obtained, for the first time, evidence of rare, non-CpG methylation in CpG island 2 of the HBV genome in infected liver. Comparing methylation of the HBV genome to three known HCC-associated host genes, APC, GSTP1, and RASSF1A, we did not identify a significant correlation between these two groups.
